Global Biosimilars Market Is Estimated To Witness High Growth Owing To Increasing Demand for Cost-effective Treatment Options and Expanding Biologics Market
The Biosimilars Market is estimated to be valued at USD 21.8 billion in 2023 and is expected to exhibit a CAGR of 15.9% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.Market Overview: The Biosimilars Market offers cost-effective treatment options that are comparable to the originator biologics. These biosimilars are highly similar to the...
0 Comentários 0 Compartilhamentos 1054 Visualizações 0 Anterior
Patrocinado